We report that transfusions of RT1 Wistar-Furth (WF) spleen cells prevented spontaneous diabetes in the RT1" BB/W rat while RT1b Buffalo rat spleen cells did not. In addition, donor origin WF T lymphocytes were detected in nondiabetic-susceptible BB/ W recipients 5 mo after transfusion. Survival of donor-origin lymphocytes may provide the cellular mechanism by which major histocompatibility complex-compatible WF spleen cell transfusions prevent BB rat diabetes.
Introduction
The BB rat develops spontaneous autoimmune diabetes that resembles human insulin-dependent diabetes mellitus (IDDM)' (1) . Affected rats abruptly become hyperglycemic and ketonemic between 60 and 120 days of age; without insulin treatment they succumb from ketoacidosis. Previous studies strongly suggest that this is an autoimmune disease process (2) . The pancreatic islets ofacutely diabetic animals are infiltrated with mononuclear cells (insulitis) (3) . Concanavalin A (Con A)-activated lymphocytes from acutely diabetic donors adoptively transfer diabetes to other rats (4) . Islet and other autoantibodies are detectable both before and after the onset of diabetes (5, 6) . The animal also exhibits depressed cell-mediated immune responses (2) due at least in part to a severe T cell lymphopenia (7, 8) .
BB rat diabetes can be prevented by various immunosuppressive and immunomodulatory procedures (2) . We reported prevention using transfusions of whole blood from a diabetesresistant subline of these rats (the "W-line") (9) . Transfusion into young diabetes-prone BB rats not only prevented diabetes and insulitis, but also restored towards normal the depressed responsiveness of BB lymphocytes to Con A. Subsequent studies identified the protective element in W-line blood and spleen 1. Abbreviations used in this paper: BUF, Buffalo; Con A, concanavalin A; MHC, major histocompatibility complex; WF, Wistar-Furth. cells as a T lymphocyte (10) , but the mechanism of its action has remained unclear.
In the present study we The rats in exp. 1 were tested for diabetes through 165 d ofage and those in exp. 2 through 175 d. Diabetes was diagnosed on the basis of 4+ glycosuria and a plasma glucose >200 mg/dl.
Histologic studies. Nondiabetic survivors in exp. 1 were killed with 100% CO2. Their pancreata were excised, fixed in Bouin's solution, stained with hematoxylin and eosin, and evaluated for the presence of insulitis. The histologist (Dr. Appel) was unaware ofthe treatment status of the animals. The rats in exp. 2 were not studied histologically.
Lymphocyte subset analysis. Samples of peripheral blood from transfused and control rats in exp. 1 were obtained at 130 d of age and analyzed for the presence of T cells bearing the helper/inducer (W3/25) or suppressor/cytotoxic (OX8) antigenic phenotype as previously described (10) .
We used monoclonal antibodies to the RT-6 and RT-7 (formerly termed ART-2 and ART-1, respectively) rat T cell differentiation al-loantigens (13-16) to determine if donor-origin T cells were present in BB/W (RT-7a) recipients of WF (RT-6b and RT-7b) or BUF (RT-6a and RT-7b) spleen cells (17) . Spleen, lymph node, and thymus cells from nondiabetic BB/W recipients obtained 5 mo after WF or BUF spleen cell transfusions were analyzed for the presence of donor-origin lymphocytes. Monoclonal antibodies to the rat T cell alloantigens RT-6. 1 (DS4.23) and RT-6.2 (6A5), and to the pan-lymphocyte alloantigen RT-7.2 (8G6. 1) were directly conjugated with fluorescein isothiocyanate. The 6A5 monoclonal antibody was the gift of Dr. D. Lubaroff, University of Iowa, Iowa City, IA; it was originally developed and characterized by Dr. C. B. Carpenter (Harvard Medical School, Boston, MA) (18) 
Results
The frequencies of diabetes and insulitis observed in exp. 1 are given in Table I . The effectiveness of W-line spleen cell transfusion in preventing diabetes was confirmed. In addition, MHCcompatible WF cells were found to provide a significant degree of protection from both diabetes and insulitis. In exp. 2, also shown in Table I , the effectiveness of WF spleen cells in preventing diabetes was independently confirmed. In contrast, MHC-incompatible RTlb BUF rat spleen cells did not prevent diabetes. These animals were not studied histologically.
In exp. 1, the absolute numbers (Xl03/mm3+SEM) of T cells in the peripheral blood of BB/W recipients of WF spleen cells (5.2±1.4) or W-line spleen cells (4.5±0.7) were increased in relation to the absolute numbers of T cells in the peripheral or BUF (RT-6a and RT-7b) spleen cells were analyzed 5 mo after completion of transfusion. Donor-origin RT-6+ T cells were present in the spleen and lymph nodes of the BB/W recipients of WF spleen cells (Table II) In additional studies, we have found that four BB/W recipients offive WF spleen cell transfusions that subsequently became diabetic had no detectable RT-6' cells, suggesting that without persistence of donor-origin lymphocytes diabetes is not prevented.
Discussion
These data confirm and extend our previous observations that transfusions ofwhole blood, spleen cells, or T lymphocytes from appropriate donors can prevent spontaneous diabetes in the BB/ W rat. They indicate that protection is not restricted to transfusions from the closely related diabetes-resistant W-line rat. Spleen cells from the MHC-compatible WF rat are equally effective. MHC-incompatible spleen cells are ineffective. Furthermore, this study extends our previous observations by using the RT-6 and RT-7 alloantigenic differences between the BB/W (RT-75) and WF (RT-6" and RT-7b) strains of rats. We are now formally able to document the long-term persistence ofdonor origin (RT-6b and RT-7b) lymphocytes in the BB/W (RT-75) recipients of transfused spleen cells. At least two mechanisms could explain the presence ofdonororigin T cells in the peripheral lymphoid tissues of BB/W recipients of WF spleen cells. The spleen contains a heterogeneous population that consists of stem cells, progenitor cells, and mature lymphocytes (19) . Since the BB/W recipients were not analyzed until 5 mo after spleen cell transfusion, the WF lympho- cytes could have been generated by the engraftment of an immature stem and/or progenitor cell population in the BB/W recipients. A more likely explanation is that the mature T lymphocyte population in the spleen cell inoculum survived in the MHCcompatible BB/W hosts. Based on the assumption that the splenic T cell population represents -40% ofthe total peripheral T cells in an adult rat (20) , it can be calculated from the data in Table II (21) . We have also demonstrated that BB/W rats lack the RT-6 T cell subset (17) that comprises -70% of the peripheral T cells in normal rats (13) (14) (15) . When taken together, these results suggest that the RT-6+, W3/25+ T cell subset may be of particular importance in the pathogenesis and/or prevention of BB rat diabetes. However, the exact cell type that confers protection as well as the mechanism by which it acts remain to be determined.
